In a double-blind, randomised, vehicle-controlled study, patients with diabetes were randomised to receive either nepafenac eye drops or placebo 3 times daily. Medication was initiated the day prior to surgery, and continued on the day of surgery and for up to 90 days of the postoperative period. The study showed that a significantly greater proportion of patients developed macular oedema in the vehicle group (16.7%) than in the nepafenac group (3.2%).
Click to search or browse MIMS
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Access the full drug database and quick-reference tables on the go